» Articles » PMID: 28774749

Sexual and Reproductive Health Behaviors and Experiences Reported by Young Women with Cystic Fibrosis

Overview
Journal J Cyst Fibros
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2017 Aug 5
PMID 28774749
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The prevalence of general and disease-specific sexual and reproductive health (SRH) concerns is unknown in the United States (U.S.) female CF population. This study aimed to describe and compare the SRH experiences and behaviors of young women with CF with the general U.S.

Population:

Methods: Young women with CF ages 15-24years from five geographically diverse U.S. CF centers participated in a survey investigating SRH. Results were summarized and compared to the U.S. National Survey of Family Growth (NSFG) using logistic regression adjusting for confounders.

Findings: A total of 188 young women with CF (mean age 19.7±2.7years) completed the survey; data were compared to 1997 NSFG respondents (mean age 19.6±0.10years). Fifty-four percent of women with CF reported having had vaginal sex with a male partner compared to 66% of U.S. women (p=0.55). Women with CF were less likely to have ever used contraception (55% vs. 74%, p=0.0001) or have been tested for sexually transmitted infections in the past year (19% vs. 34%, p=0.001) compared to the general population. Two percent of women with CF reported having ever been pregnant compared to 24% of U.S. women (p<0.0001). One-third of young women with CF reported perceived pubertal delay, 16% urinary incontinence, 16% sexual dysfunction, and 49% yeast infections.

Interpretation: Young women with CF face significant SRH concerns and appear to be experiencing gaps in SRH care provision. Opportunities exist for intervention development around this aspect of comprehensive CF care.

Funding: CF Foundation (KAZMER15A0); U.S. National Institutes of Health (UL1TR000005).

Citing Articles

Anesthetic Management and Considerations for Cesarean Delivery in a Patient With Cystic Fibrosis.

Pham R, Mehdizadeh C, Baker C, Soloniuk L, Pasca I, Sinha A Case Rep Anesthesiol. 2025; 2025:6388254.

PMID: 39881848 PMC: 11774568. DOI: 10.1155/cria/6388254.


Assessing the health impacts of parenthood on people with cystic fibrosis: the HOPeCF prospective cohort protocol.

Kazmerski T, Stransky O, Lee M, Prangley K, Jain R, Georgiopoulos A BMJ Open Respir Res. 2024; 11(1).

PMID: 39209351 PMC: 11367319. DOI: 10.1136/bmjresp-2024-002383.


Cystic fibrosis.

Mall M, Burgel P, Castellani C, Davies J, Salathe M, Taylor-Cousar J Nat Rev Dis Primers. 2024; 10(1):53.

PMID: 39117676 DOI: 10.1038/s41572-024-00538-6.


Insights and advances in recurrent vulvovaginal candidiasis.

San Juan Galan J, Poliquin V, Gerstein A PLoS Pathog. 2023; 19(11):e1011684.

PMID: 37948448 PMC: 10637712. DOI: 10.1371/journal.ppat.1011684.


Web-Based Survey Piloting Process as a Model for Developing and Testing Past Contraceptive Use and Pregnancy History: Cystic Fibrosis Case Study.

Godfrey E, Schwartz M, Stukovsky K, Woodward D, Magaret A, Aitken M JMIR Form Res. 2023; 7:e46395.

PMID: 37463015 PMC: 10394597. DOI: 10.2196/46395.